TGFBR2 and melanoma: To examine the phenotype and function of tumor antigen-specific CD8+ T cells by TβRII+ EVs, we injected OT-I TCR transgenic mice with B16 melanoma cells expressing MHC class I specific epitope of OVA (B16-OVA) (Fig. 7g).